No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year (Q33638583)

28 July 2017

title

No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year (English)

1 reference

28 July 2017

0 references

1 reference

Monica Sneve

2

0 references

Rolf Jorde

series ordinal

1

object named as

Rolf Jorde

1 reference

28 July 2017

4

Yngve Figenschau

1 reference

28 July 2017

Peter A Torjesen

3

1 reference

28 July 2017

John-Bjarne Hansen

series ordinal

5

1 reference

28 July 2017

Guri Grimnes

series ordinal

6

1 reference

28 July 2017

publication date

7 January 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

9

1 reference

28 July 2017

page(s)

1

1 reference

Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Functions of RANKL/RANK/OPG in bone modeling and remodeling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Vitamin D, osteoclastogenesis and bone resorption: from mechanistic insight to the development of new analogs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Vitamin D and disease prevention with special reference to cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Overview of general physiologic features and functions of vitamin D.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818614

Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Serum levels of osteoprotegerin increase with age in a healthy adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Vitamin D Action and Regulation of Bone Remodeling: Suppression of Osteoclastogenesis by the Mature Osteoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-1

Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells

21 January 2018

1 reference

12 December 2020

Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans

1 reference

12 December 2020

The urgent need to recommend an intake of vitamin D that is effective

1 reference

12 December 2020

Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity

1 reference

12 December 2020

The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study

1 reference

12 December 2020

Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen

1 reference

12 December 2020

Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women

1 reference

12 December 2020

Identifiers

DOI

10.1186/1475-2891-9-1

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference